Table 1.
Location | |||
Pharmacy (n=5100) | Non-pharmacy (n=72 398) | P value | |
Sex, female (%) | 3016 (59.1) | 42 170 (58.2) | 0.218 |
Age, years (mean (SD)) | 46.52 (17.02) | 51.90 (21.23) | <0.001 |
Age, years (minimum, maximum) | 10, 99 | 10, 101 | |
Age group, years | <0.001 | ||
<18 | 371 (7.3) | 7314 (10.1) | |
18–64 | 4196 (82.3) | 38 042 (52.5) | |
≥65 | 533 (10.5) | 27 042 (37.4) | |
Vaccine brand (%) | <0.001 | ||
Afluria Quad | 1974 (38.7) | 8517 (11.8) | |
Fluad Quad | 514 (10.1) | 26 420 (36.5) | |
Fluarix Tetra | 1119 (21.9) | 6862 (9.5) | |
FluQuadri | 914 (17.9) | 26 578 (36.7) | |
Fluzone High-Dose | 0 (0) | 2 (0) | |
Influvac Tetra | 567 (11.1) | 1416 (2) | |
Vaxigrip Tetra | 12 (0.2) | 2600 (3.6) | |
SMS response time, minutes (median (IQR))* | 13 (3 to 72) | 14 (4 to 70) | 0.006 |
Responses received to SMS1 within 24 hours (%) | 4939 (96.8) | 69 549 (96.1) | 0.006 |
Values are count (proportion), mean (SD) or median (IQR) as indicated. P values are calculated from the χ2 test for categorical variables and the independent samples t-test for continuous variables.
*The p value for SMS response time was calculated using the Mann-Whitney Wilcoxon Test.
SMS, short message service.